| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/26/2023 | 8.19% | Barclays | $350 → $340 | Maintains | Equal-Weight |
| 10/18/2023 | 20.92% | JP Morgan | $390 → $380 | Maintains | Overweight |
| 10/03/2023 | 5.65% | Morgan Stanley | $345 → $332 | Maintains | Equal-Weight |
| 09/18/2023 | 28.56% | RBC Capital | → $404 | Reiterates | Outperform → Outperform |
| 09/14/2023 | 24.1% | Wolfe Research | → $390 | Initiates Coverage On | → Outperform |
| 07/27/2023 | 26.96% | BMO Capital | $390 → $399 | Maintains | Outperform |
| 07/26/2023 | 9.78% | Morgan Stanley | $323 → $345 | Maintains | Equal-Weight |
| 07/26/2023 | 28.56% | RBC Capital | $350 → $404 | Maintains | Outperform |
| 07/26/2023 | 16.15% | Wells Fargo | $346 → $365 | Maintains | Equal-Weight |
| 07/13/2023 | 10.1% | Wells Fargo | $312 → $346 | Maintains | Equal-Weight |
| 07/10/2023 | 2.78% | Morgan Stanley | $300 → $323 | Maintains | Equal-Weight |
| 06/15/2023 | 27.28% | B of A Securities | → $400 | Initiates Coverage On | → Buy |
| 05/17/2023 | 14.55% | BMO Capital | $355 → $360 | Maintains | Outperform |
| 05/09/2023 | -0.72% | Wells Fargo | → $312 | Initiates Coverage On | → Equal-Weight |
| 04/26/2023 | 11.37% | RBC Capital | → $350 | Reiterates | → Outperform |
| 04/26/2023 | 11.37% | Credit Suisse | → $350 | Reiterates | → Outperform |
| 04/26/2023 | 3.42% | UBS | $308 → $325 | Maintains | Neutral |
| 04/06/2023 | -5.81% | Morgan Stanley | $293 → $296 | Maintains | Equal-Weight |
| 04/04/2023 | 11.05% | Oppenheimer | $342 → $349 | Maintains | Outperform |
| 02/01/2023 | 8.83% | Oppenheimer | $309 → $342 | Maintains | Outperform |
| 02/01/2023 | 11.37% | Baird | $289 → $350 | Maintains | Outperform |
| 02/01/2023 | -4.54% | Barclays | $275 → $300 | Maintains | Equal-Weight |
| 02/01/2023 | — | Raymond James | Downgrades | Outperform → Market Perform | |
| 01/10/2023 | -1.04% | Raymond James | $284 → $311 | Maintains | Outperform |
| 01/04/2023 | -6.77% | Morgan Stanley | $294 → $293 | Maintains | Equal-Weight |
| 12/06/2022 | -6.45% | Morgan Stanley | $271 → $294 | Maintains | Equal-Weight |
| 12/02/2022 | -12.49% | Barclays | $250 → $275 | Maintains | Equal-Weight |
| 11/23/2022 | -6.13% | Goldman Sachs | $261 → $295 | Maintains | Neutral |
| 11/23/2022 | -1.36% | Oppenheimer | $288 → $310 | Maintains | Outperform |
| 11/17/2022 | -13.77% | Morgan Stanley | $255 → $271 | Maintains | Equal-Weight |
| 11/02/2022 | -4.54% | Argus Research | $340 → $300 | Maintains | Buy |
| 10/26/2022 | -18.86% | Morgan Stanley | $281 → $255 | Maintains | Equal-Weight |
| 10/26/2022 | -20.45% | Barclays | $285 → $250 | Maintains | Equal-Weight |
| 10/26/2022 | -4.54% | RBC Capital | $329 → $300 | Maintains | Outperform |
| 10/26/2022 | -9.63% | Raymond James | $303 → $284 | Maintains | Outperform |
| 10/21/2022 | -17.27% | Deutsche Bank | $324 → $260 | Maintains | Hold |
| 10/12/2022 | -25.22% | Stifel | $259 → $235 | Maintains | Hold |
| 10/11/2022 | -3.58% | Raymond James | $321 → $303 | Maintains | Outperform |
| 10/03/2022 | -10.58% | Morgan Stanley | $288 → $281 | Maintains | Equal-Weight |
| 10/03/2022 | -16.31% | Goldman Sachs | $296 → $263 | Maintains | Neutral |
| 09/27/2022 | -8.36% | Morgan Stanley | $283 → $288 | Maintains | Equal-Weight |
| 08/19/2022 | 10.74% | Oppenheimer | $313 → $348 | Maintains | Outperform |
| 08/15/2022 | 12.01% | BMO Capital | $309 → $352 | Maintains | Outperform |
| 08/10/2022 | 3.1% | Deutsche Bank | → $324 | Downgrades | Buy → Hold |
| 07/27/2022 | -9.95% | Morgan Stanley | $298 → $283 | Maintains | Equal-Weight |
| 07/27/2022 | 2.14% | Raymond James | $327 → $321 | Maintains | Outperform |
| 07/12/2022 | 4.05% | Raymond James | $364 → $327 | Maintains | Outperform |
| 07/07/2022 | -5.17% | Morgan Stanley | $305 → $298 | Maintains | Equal-Weight |
| 06/08/2022 | — | Atlantic Equities | Downgrades | Overweight → Neutral | |
| 06/07/2022 | 4.69% | RBC Capital | $344 → $329 | Maintains | Outperform |
| 06/06/2022 | -8.36% | UBS | $308 → $288 | Maintains | Neutral |
| 06/03/2022 | -9.31% | Barclays | $350 → $285 | Downgrades | Overweight → Equal-Weight |
| 06/02/2022 | 3.1% | Deutsche Bank | $372 → $324 | Maintains | Buy |
| 06/02/2022 | -1.67% | BMO Capital | $331 → $309 | Maintains | Outperform |
| 06/02/2022 | -2.95% | Morgan Stanley | $318 → $305 | Maintains | Equal-Weight |
| 05/03/2022 | 18.37% | Deutsche Bank | $408 → $372 | Maintains | Buy |
| 05/03/2022 | 1.19% | Morgan Stanley | $350 → $318 | Maintains | Equal-Weight |
| 05/03/2022 | 11.37% | Barclays | $400 → $350 | Maintains | Overweight |
| 05/03/2022 | 11.37% | Credit Suisse | $395 → $350 | Maintains | Outperform |
| 05/03/2022 | 9.46% | RBC Capital | $403 → $344 | Maintains | Outperform |
| 05/03/2022 | 15.83% | Raymond James | $417 → $364 | Maintains | Outperform |
| 04/18/2022 | 19.33% | BMO Capital | $365 → $375 | Maintains | Outperform |
| 04/07/2022 | 32.69% | Raymond James | $439 → $417 | Maintains | Outperform |
| 04/04/2022 | 11.37% | Morgan Stanley | $360 → $350 | Maintains | Equal-Weight |
| 03/30/2022 | 29.83% | Deutsche Bank | → $408 | Initiates Coverage On | → Buy |
| 03/11/2022 | 14.55% | Morgan Stanley | $378 → $360 | Maintains | Equal-Weight |
| 03/11/2022 | 16.15% | BMO Capital | $402 → $365 | Maintains | Outperform |
| 03/11/2022 | 25.69% | Credit Suisse | $415 → $395 | Maintains | Outperform |
| 03/11/2022 | 27.28% | Barclays | $450 → $400 | Maintains | Overweight |
| 03/08/2022 | 15.51% | Baird | → $363 | Initiates Coverage On | → Outperform |
| 03/04/2022 | 22.51% | Stifel | $400 → $385 | Maintains | Hold |
| 02/14/2022 | 27.92% | BMO Capital | $430 → $402 | Maintains | Outperform |
| 02/11/2022 | 20.28% | Morgan Stanley | $417 → $378 | Maintains | Equal-Weight |
| 02/11/2022 | 32.06% | Credit Suisse | $475 → $415 | Maintains | Outperform |
| 01/10/2022 | 39.69% | Raymond James | $436 → $439 | Maintains | Outperform |
| 01/05/2022 | 32.69% | Morgan Stanley | $402 → $417 | Maintains | Equal-Weight |
| 10/29/2021 | 43.19% | RBC Capital | $414 → $450 | Maintains | Outperform |
| 10/29/2021 | 51.15% | Credit Suisse | $425 → $475 | Maintains | Outperform |
| 10/29/2021 | 27.92% | Morgan Stanley | $372 → $402 | Maintains | Equal-Weight |
| 10/29/2021 | 37.15% | Oppenheimer | $428 → $431 | Maintains | Outperform |
| 10/05/2021 | 32.37% | Raymond James | $406 → $416 | Maintains | Outperform |
| 09/07/2021 | 33.01% | Oppenheimer | $406 → $418 | Maintains | Outperform |
| 07/29/2021 | 18.37% | Morgan Stanley | $344 → $372 | Maintains | Equal-Weight |
| 07/29/2021 | 29.19% | Oppenheimer | $387 → $406 | Maintains | Outperform |
| 07/29/2021 | 24.74% | UBS | $383 → $392 | Downgrades | Buy → Neutral |
| 07/29/2021 | 29.19% | Raymond James | $394 → $406 | Maintains | Outperform |
| 07/08/2021 | 9.46% | Morgan Stanley | $322 → $344 | Maintains | Equal-Weight |
| 07/08/2021 | 30.15% | RBC Capital | → $409 | Initiates Coverage On | → Outperform |
| 07/07/2021 | 25.37% | Raymond James | $341 → $394 | Maintains | Outperform |
| 07/06/2021 | 19.65% | Stifel | $322 → $376 | Maintains | Hold |
| 04/29/2021 | 13.6% | Oppenheimer | $337 → $357 | Maintains | Outperform |
| 04/29/2021 | 2.46% | Morgan Stanley | $301 → $322 | Maintains | Equal-Weight |
| 04/14/2021 | 10.74% | BMO Capital | $312 → $348 | Maintains | Outperform |
| 04/12/2021 | -4.22% | Morgan Stanley | $292 → $301 | Maintains | Equal-Weight |
| 04/01/2021 | 7.24% | Raymond James | → $337 | Upgrades | Market Perform → Outperform |
| 03/24/2021 | 0.24% | Deutsche Bank | $300 → $315 | Maintains | Hold |
| 01/06/2021 | -7.08% | Morgan Stanley | $300 → $292 | Maintains | Equal-Weight |
| 11/30/2020 | -4.54% | Deutsche Bank | → $300 | Initiates Coverage On | → Hold |
| 10/30/2020 | -4.54% | Morgan Stanley | $292 → $300 | Maintains | Equal-Weight |
| 10/12/2020 | -7.08% | Morgan Stanley | $275 → $292 | Maintains | Equal-Weight |
| 10/06/2020 | 17.1% | UBS | $358 → $368 | Maintains | Buy |
| 10/02/2020 | -5.81% | Stifel | $293 → $296 | Maintains | Hold |
| 07/31/2020 | 13.92% | UBS | $344 → $358 | Maintains | Buy |
| 07/31/2020 | -12.49% | Morgan Stanley | $278 → $275 | Maintains | Equal-Weight |
| 07/29/2020 | -11.54% | Morgan Stanley | $261 → $278 | Maintains | Equal-Weight |
| 07/08/2020 | 9.46% | UBS | $270 → $344 | Maintains | Buy |
| 07/08/2020 | -16.95% | Morgan Stanley | $248 → $261 | Maintains | Equal-Weight |
| 06/03/2020 | -21.08% | Morgan Stanley | $228 → $248 | Maintains | Equal-Weight |
| 05/29/2020 | -9.31% | Credit Suisse | → $285 | Initiates Coverage On | → Outperform |
| 05/19/2020 | -7.72% | Oppenheimer | → $290 | Initiates Coverage On | → Outperform |
| 05/01/2020 | -31.59% | Wells Fargo | $210 → $215 | Maintains | Equal-Weight |
| 05/01/2020 | -14.08% | UBS | $238 → $270 | Maintains | Buy |
| 05/01/2020 | -27.45% | Morgan Stanley | $211 → $228 | Maintains | Equal-Weight |
| 04/06/2020 | -24.27% | UBS | $260 → $238 | Maintains | Buy |
| 03/12/2020 | -25.54% | Morgan Stanley | $240 → $234 | Maintains | Equal-Weight |
| 02/18/2020 | 3.42% | Argus Research | $245 → $325 | Maintains | Buy |
| 02/13/2020 | -11.22% | Stifel | $266 → $279 | Maintains | Hold |
| 02/13/2020 | -15.36% | Cantor Fitzgerald | $233 → $266 | Maintains | Neutral |
| 02/13/2020 | -12.49% | Wells Fargo | $215 → $275 | Maintains | Equal-Weight |
| 01/07/2020 | — | Morgan Stanley | Upgrades | Underweight → Equal-Weight | |
| 10/31/2019 | -18.22% | UBS | $245 → $257 | Maintains | Buy |
| 10/31/2019 | -42.4% | Morgan Stanley | $176 → $181 | Maintains | Underweight |
| 10/07/2019 | -44% | Morgan Stanley | $173 → $176 | Maintains | Underweight |
| 10/07/2019 | -22.04% | UBS | $215 → $245 | Upgrades | Neutral → Buy |
| 09/10/2019 | -44.95% | Morgan Stanley | $170 → $173 | Maintains | Underweight |
| 08/01/2019 | -23.63% | JP Morgan | $220 → $240 | Maintains | Overweight |
| 08/01/2019 | -31.59% | UBS | $200 → $215 | Maintains | Neutral |
| 08/01/2019 | -27.45% | Stifel | $214 → $228 | Maintains | Hold |
| 07/10/2019 | -47.81% | Morgan Stanley | $150 → $164 | Maintains | Underweight |
| 07/10/2019 | -36.36% | UBS | $198 → $200 | Maintains | Neutral |
| 07/10/2019 | -29.99% | JP Morgan | → $220 | Initiates Coverage On | → Overweight |
| 06/11/2019 | -52.27% | Morgan Stanley | $145 → $150 | Maintains | Underweight |
| 04/25/2019 | -37.95% | Wells Fargo | $170 → $195 | Maintains | Market Perform |
| 04/25/2019 | -38.27% | BMO Capital | $189 → $194 | Maintains | Market Perform |
| 04/25/2019 | -38.9% | Cantor Fitzgerald | $168 → $192 | Maintains | Neutral |
| 04/09/2019 | -36.99% | UBS | $170 → $198 | Maintains | Neutral |
| 04/05/2019 | -34.77% | Piper Sandler | $178 → $205 | Maintains | Neutral |
| 01/08/2019 | -51% | UBS | $156 → $154 | Maintains | Neutral |
| 01/08/2019 | — | Morgan Stanley | Downgrades | Equal-Weight → Underweight | |
| 01/07/2019 | -47.5% | Barclays | $175 → $165 | Maintains | Overweight |
| 11/14/2018 | -47.5% | Goldman Sachs | → $165 | Initiates Coverage On | → Neutral |
| 10/30/2018 | -45.9% | Wells Fargo | $172 → $170 | Maintains | Market Perform |
| 10/29/2018 | -50.36% | Morgan Stanley | $171 → $156 | Maintains | Equal-Weight |
What is the target price for Moody's (MCO)?
The latest price target for Moody's (NYSE: MCO) was reported by Barclays on October 26, 2023. The analyst firm set a price target for $340.00 expecting MCO to rise to within 12 months (a possible 8.19% upside). 31 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Moody's (MCO)?
The latest analyst rating for Moody's (NYSE: MCO) was provided by Barclays, and Moody's maintained their equal-weight rating.
When is the next analyst rating going to be posted or updated for Moody's (MCO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Moody's, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Moody's was filed on October 26, 2023 so you should expect the next rating to be made available sometime around October 26, 2024.
Is the Analyst Rating Moody's (MCO) correct?
While ratings are subjective and will change, the latest Moody's (MCO) rating was a maintained with a price target of $350.00 to $340.00. The current price Moody's (MCO) is trading at is $314.26, which is out of the analyst's predicted range.